BCM
NPTN

Bayesian Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bayesian Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,656
Closed -$126K – 708
2020
Q3 		$126K Sell
20,656
-8,344
-29% -$63.7K 0.03% 467
2020
Q2 		$258K Sell
29,000
-9,991
-26% -$86.1K 0.06% 386
2020
Q1 		$283K Buy
38,991
+11,000
+39% +$81.5K 0.06% 477
2019
Q4 		$247K Buy
+27,991
New +$209K 0.04% 479
2018
Q1 		– Sell
-10,200
Closed -$67K – 882
2017
Q4 		$67K Buy
+10,200
New +$62.3K 0.01% 522

Other funds holding NPTN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Bayesian Capital Management's NPTN Position: Q4 2020 in Review

Bayesian Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q4 2020, closing a stake of 20,656 shares — an estimated $126K sold.

Bayesian Capital Management first reported a position in NPTN in Q4 2017 and held it in 5 quarters. The position peaked at $283K in Q1 2020. 138 funds tracked by Wall St. Rank hold NPTN as of Q4 2020.

  • Bayesian Capital Management reported no remaining NEOPHOTONICS CORP position as of Q4 2020 after selling out during the quarter.
  • Bayesian Capital Management sold 20,656 NEOPHOTONICS CORP shares in Q4 2020, an estimated $126K.
  • Bayesian Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2017 and held it in 5 quarters.
  • Bayesian Capital Management's NEOPHOTONICS CORP position peaked at $283K in Q1 2020.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2020.

Based on Bayesian Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.